Moore Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29,993
| Closed | -$672K | – | 564 |
|
|
2022
Q3 | $672K | Buy |
+29,993
| New | +$672K | 0.02% | 408 |
|
|
2022
Q2 | – | Sell |
-22,943
| Closed | -$890K | – | 705 |
|
|
2022
Q1 | $890K | Buy |
+22,943
| New | +$890K | 0.02% | 418 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$2.17M | – | 800 |
|
|
2021
Q2 | $2.17M | Sell |
25,000
-23,431
| -48% | -$2.03M | 0.03% | 423 |
|
|
2021
Q1 | $3.99M | Sell |
48,431
-31,129
| -39% | -$2.57M | 0.05% | 303 |
|
|
2020
Q4 | $7.23M | Buy |
79,560
+29,560
| +59% | +$2.69M | 0.08% | 158 |
|
|
2020
Q3 | $2M | Hold |
50,000
| – | – | 0.04% | 241 |
|
|
2020
Q2 | $1.72M | Buy |
50,000
+25,900
| +107% | +$889K | 0.05% | 183 |
|
|
2020
Q1 | $535K | Buy |
+24,100
| New | +$535K | 0.02% | 130 |
|